位置:首页 > 蛋白库 > AKRMG_ECOLI
AKRMG_ECOLI
ID   AKRMG_ECOLI             Reviewed;         326 AA.
AC   P77256;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   03-AUG-2022, entry version 148.
DE   RecName: Full=NADH-specific methylglyoxal reductase {ECO:0000303|PubMed:16813561};
DE            EC=1.1.1.- {ECO:0000269|PubMed:16813561};
DE   AltName: Full=AKR11B2 {ECO:0000303|PubMed:16813561};
GN   Name=ydjG; OrderedLocusNames=b1771, JW1760;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9097039; DOI=10.1093/dnares/3.6.363;
RA   Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K., Itoh T.,
RA   Kasai H., Kashimoto K., Kimura S., Kitakawa M., Kitagawa M., Makino K.,
RA   Miki T., Mizobuchi K., Mori H., Mori T., Motomura K., Nakade S.,
RA   Nakamura Y., Nashimoto H., Nishio Y., Oshima T., Saito N., Sampei G.,
RA   Seki Y., Sivasundaram S., Tagami H., Takeda J., Takemoto K., Takeuchi Y.,
RA   Wada C., Yamamoto Y., Horiuchi T.;
RT   "A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to
RT   the 28.0-40.1 min region on the linkage map.";
RL   DNA Res. 3:363-377(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE
RP   SPECIFICITY, SUBUNIT, MUTAGENESIS OF ASP-232, AND 3D-STRUCTURE MODELING.
RX   PubMed=16813561; DOI=10.1042/bj20060660;
RA   Di Luccio E., Elling R.A., Wilson D.K.;
RT   "Identification of a novel NADH-specific aldo-keto reductase using sequence
RT   and structural homologies.";
RL   Biochem. J. 400:105-114(2006).
RN   [5]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND INDUCTION.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=20562286; DOI=10.1128/aem.00242-10;
RA   Vogel-Scheel J., Alpert C., Engst W., Loh G., Blaut M.;
RT   "Requirement of purine and pyrimidine synthesis for colonization of the
RT   mouse intestine by Escherichia coli.";
RL   Appl. Environ. Microbiol. 76:5181-5187(2010).
RN   [6]
RP   BIOTECHNOLOGY.
RX   PubMed=22074179; DOI=10.1186/1475-2859-10-97;
RA   Jain R., Yan Y.;
RT   "Dehydratase mediated 1-propanol production in metabolically engineered
RT   Escherichia coli.";
RL   Microb. Cell Fact. 10:97-97(2011).
CC   -!- FUNCTION: Catalyzes the NADH-dependent reduction of methylglyoxal (2-
CC       oxopropanal) in vitro (PubMed:16813561). It is not known if this
CC       activity has physiological significance (PubMed:16813561). Cannot use
CC       NADPH as a cosubstrate (PubMed:16813561). Seems to play some role in
CC       intestinal colonization (PubMed:20562286).
CC       {ECO:0000269|PubMed:16813561, ECO:0000269|PubMed:20562286}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hydroxyacetone + NAD(+) = H(+) + methylglyoxal + NADH;
CC         Xref=Rhea:RHEA:35615, ChEBI:CHEBI:15378, ChEBI:CHEBI:17158,
CC         ChEBI:CHEBI:27957, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000269|PubMed:16813561};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=52 uM for NADH {ECO:0000269|PubMed:16813561};
CC         KM=1.81 mM for methylglyoxal {ECO:0000269|PubMed:16813561};
CC         KM=363 mM for DL-glyceraldehyde {ECO:0000269|PubMed:16813561};
CC         Note=kcat is 15.7 sec(-1) with methylglyoxal as substrate. kcat is 2
CC         sec(-1) with DL-glyceraldehyde as substrate.
CC         {ECO:0000269|PubMed:16813561};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:16813561}.
CC   -!- INDUCTION: Is 3.5-fold up-regulated in vivo in intestinal environment
CC       compared to the level for in vitro cultures.
CC       {ECO:0000269|PubMed:20562286}.
CC   -!- DISRUPTION PHENOTYPE: Deletion of this gene affects intestinal
CC       colonization by E.coli, since a deletion mutant reaches a 1.2-log-lower
CC       cecal concentration than the wild-type. {ECO:0000269|PubMed:20562286}.
CC   -!- BIOTECHNOLOGY: Can be used in an engineered metabolic pathway for 1,2-
CC       propanediol and 1-propanol production. 1-propanol is a potential fuel
CC       substitute to petroleum. {ECO:0000269|PubMed:22074179}.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family. Aldo/keto
CC       reductase 11 subfamily. {ECO:0000305|PubMed:16813561}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U00096; AAC74841.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15562.1; -; Genomic_DNA.
DR   PIR; C64937; C64937.
DR   RefSeq; NP_416285.1; NC_000913.3.
DR   RefSeq; WP_000723710.1; NZ_SSZK01000001.1.
DR   AlphaFoldDB; P77256; -.
DR   SMR; P77256; -.
DR   BioGRID; 4259143; 11.
DR   IntAct; P77256; 3.
DR   STRING; 511145.b1771; -.
DR   PaxDb; P77256; -.
DR   PRIDE; P77256; -.
DR   EnsemblBacteria; AAC74841; AAC74841; b1771.
DR   EnsemblBacteria; BAA15562; BAA15562; BAA15562.
DR   GeneID; 946283; -.
DR   KEGG; ecj:JW1760; -.
DR   KEGG; eco:b1771; -.
DR   PATRIC; fig|1411691.4.peg.483; -.
DR   EchoBASE; EB3256; -.
DR   eggNOG; COG0667; Bacteria.
DR   HOGENOM; CLU_023205_2_3_6; -.
DR   InParanoid; P77256; -.
DR   OMA; FGCSTFP; -.
DR   PhylomeDB; P77256; -.
DR   BioCyc; EcoCyc:G6958-MON; -.
DR   BioCyc; MetaCyc:G6958-MON; -.
DR   SABIO-RK; P77256; -.
DR   PRO; PR:P77256; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0103030; F:ethylglyoxal reductase (NADH-dependent, hydroxyacetone-forming) activity; IEA:RHEA.
DR   GO; GO:0019170; F:methylglyoxal reductase (NADH-dependent) activity; IDA:EcoCyc.
DR   Gene3D; 3.20.20.100; -; 1.
DR   InterPro; IPR020471; AKR.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   InterPro; IPR036812; NADP_OxRdtase_dom_sf.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   PRINTS; PR00069; ALDKETRDTASE.
DR   SUPFAM; SSF51430; SSF51430; 1.
PE   1: Evidence at protein level;
KW   NAD; Oxidoreductase; Reference proteome.
FT   CHAIN           1..326
FT                   /note="NADH-specific methylglyoxal reductase"
FT                   /id="PRO_0000070395"
FT   ACT_SITE        59
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P80874"
FT   BINDING         20..21
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P80874"
FT   BINDING         54
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P80874"
FT   BINDING         189
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P80874"
FT   BINDING         217..222
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P80874"
FT   BINDING         291
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P80874"
FT   BINDING         297
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P80874"
FT   SITE            85
FT                   /note="Lowers pKa of active site Tyr"
FT                   /evidence="ECO:0000250|UniProtKB:P80874"
FT   MUTAGEN         232
FT                   /note="D->A,E: Converts the protein into an enzyme with
FT                   dual specificity, i.e. that is able to use both NADPH and
FT                   NADH as cosubstrates."
FT                   /evidence="ECO:0000269|PubMed:16813561"
SQ   SEQUENCE   326 AA;  36329 MW;  1FF5C52522708978 CRC64;
     MKKIPLGTTD ITLSRMGLGT WAIGGGPAWN GDLDRQICID TILEAHRCGI NLIDTAPGYN
     FGNSEVIVGQ ALKKLPREQV VVETKCGIVW ERKGSLFNKV GDRQLYKNLS PESIREEVAA
     SLQRLGIDYI DIYMTHWQSV PPFFTPIAET VAVLNELKSE GKIRAIGAAN VDADHIREYL
     QYGELDIIQA KYSILDRAME NELLPLCRDN GIVVQVYSPL EQGLLTGTIT RDYVPGGARA
     NKVWFQRENM LKVIDMLEQW QPLCARYQCT IPTLALAWIL KQSDLISILS GATAPEQVRE
     NVAALNINLS DADATLMREM AEALER
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024